ELRIG Drug Discovery 2026
Join Pharmaron at ELRIG Drug Discovery 2026
Pharmaron is delighted to present and exhibit at ELRIG UK Drug Discovery 2026 at the ExCel in London this October 14 – 15, 2026. We are available to discuss how we can support you in delivering drug discovery programs from target ID to the clinic and beyond.
We would love to chat about our recent developments in the field of PARP-1 and Fragment-Based Drug Discovery, alongside Biophysical and PBPK Modelling Approaches.
Join us at ELRIG and connect with our attending team.
- Marta Westwood – Director, Biophysics
- Michael Bestwick – Director, DMPK
- Chris Wellaway – Director, Medicinal Chemistry
- Tammy Ladduwahetty – Director, Medicinal Chemistry
- Elnaz Gozalpour – Associate Director, DMPK
- Dave Lugo – Associate Principal Scientist, Integrated Drug Discovery
- François Saint-Dizier – Associate Principal Scientist, Medicinal Chemistry
- Marta Nawrocka – Associate Principal Scientist, Product Development
- Natalie Windle – Director, Business Development
- Catarina Rodrigues – Associate Director, Business Development
- Hannah Craig – Associate Director, Business Development
- Innocent Mushi – Senior Manager, Business Development
- Andrew Sullivan – Business Development, Operations Manager
- Shirley Lam – Associate Director, Business Development, CGT
Event Details:
- 14th – 15th October 2026
- ExCel, London, UK
Don’t miss the chance to schedule a meeting with our team to explore how we can collaborate.
Our ELRIG 2026 Schedule:
Exhibit Booth # D12
Talks
- A CNS-Focused Approach to Selective PARP1 Drug Discovery
- Thursday 15th October, 11:25 am
- Location: Exhibition Hall Theatre
- Presented by Elnaz Gozalpour (Associate Director, DMPK) & Tammy Ladduwahetty (Director, Medicinal Chemistry)
Director
Biophysics
DMPK Director
Drug Discovery
Associate Director
Medicinal Chemistry
Director
Medicinal Chemistry
Associate Director
DMPK
Associate Principal Scientist
Product Development
Associate Principal Scientist
Medicinal Chemistry
Director of Business Development
Radiolabelled Sciences
Associate Director
Business Development
Associate Director
Business Development
Senior Manager
Business Development
Associate Manager
Business Development Operations
Posters
- Poster: Interrogating Different Induced Proximity Modalities
- Presented by: Chris Wellaway (Director, Medicinal Chemistry)
- Poster: Fragment-Based Drug Discovery at Pharmaron: Library Enhancement and Case Study
- Presented by: François Saint-Dizier (Associate Principal Scientist, Medicinal Chemistry)
- Poster: Evaluation of an IDAS2-PAMPA Two Stage in vitro System for Assessing Passive Permeability of Small Molecules
- Presented by: Marta Nawrocka (Associate Principal Scientist, Product Development)
- Poster: Qualifying a Human PK Projection Strategy Approach with Clinical Data: Four Examples from Phase I
- Presented by: Elnaz Gozalpour (Associate Director, DMPK)
- Poster: Biophysics – Advancing Drug Discovery Through Biophysical Characterization of Diverse Therapeutic Modalities
- Presented by Marta Westwood (Director, Biophysics)
- Poster: Optimizing Intestinal Tissue Exposure of Locally Acting Drugs Using an in vivo-Informed PBPK Modelling Approach
- Presented by Dave Lugo (Associate Principal Scientist, Integrated Drug Discovery)
About ELRIG UK Drug Discovery 2026
Europe’s largest conference for the drug discovery community returns to London, with scientific tracks covering not only therapeutic themes such as mechanisms of aging and cell & gene therapy but also more practical aspects of drug discovery encompassing advances in assay design, applications in high content imaging, target identification, and disease modeling.
For more information about ELRIG and to register, check out the ELRIG UK Drug Discovery website.
Request a Meeting
Meeting Request Form
Meeting requests during a conference or event
